Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partners Eli Loots, Ph.D. and Mike Fuller Discuss “Authorised Biosimilars” in BioPharm Insight

March 3, 2016  | Michael L. Fuller

Partners Eli Loots, Ph.D. and Mike Fuller were interviewed for the article “Biosimilars could follow route of authorised generics though technical, market hurdles draw timeline uncertainty” in BioPharm Insight. 

Read the full article on the BioPharm Insight website >> (Subscription required)

Partners Eli Loots, Ph.D. and Mike Fuller Discuss “Authorised Biosimilars” in BioPharm Insight Headshot

Michael L. Fuller
Partner
San Diego
mike.fuller@knobbe.com
858-707-4000

Related Links

Industries

News & Insights

News
Jan 2026
Knobbe Martens Announces Six New Partners in Offices Across the Country
New partner class strengthens Knobbe Martens’ position as a leader in IP Law IRVINE, Calif., January 5, 2026 – Knobbe Martens, a leading intellectual property and technology law firm, is...
Blog - Biotechnology
Dec 2025
Life Science Considerations on the USPTO’s New Guidelines for AI-Assisted Inventorship
On November 26, 2025, the United States Patent and Trademark Office (USPTO) issued revised guidelines for determining inventorship of AI-assisted inventions,[1] which is a significant development in life science innovations,...
Publications
Dec 2025
Knobbe Martens Partners Sean Murray and Jeremiah Helm Examine Federal Circuit Guidance on Patent Wording in Law360
In the latest installment of their monthly Law360 column on recent significant Federal Circuit cases, Knobbe Martens partners Sean Murray and Jeremiah Helm analyze the court’s ruling in Barrette Outdoor...